tradingkey.logo
tradingkey.logo
検索

Lifecore Biomedical Inc

LFCR
ウォッチリストに追加
5.090USD
-0.180-3.42%
終値 07/02, 13:00ET15分遅れの株価
190.76M時価総額
損失額直近12ヶ月PER

詳細情報 Lifecore Biomedical Inc 企業名

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Incの企業情報

企業コードLFCR
会社名Lifecore Biomedical Inc
上場日Feb 15, 1996
最高経営責任者「CEO」Josephs (Paul)
従業員数406
証券種類Ordinary Share
決算期末Feb 15
本社所在地3515 Lyman Boulevard
都市CHASKA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号55318
電話番号19523684300
ウェブサイトhttps://www.lifecore.com/
企業コードLFCR
上場日Feb 15, 1996
最高経営責任者「CEO」Josephs (Paul)

Lifecore Biomedical Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--
Mr. Christopher S. Kiper
Mr. Christopher S. Kiper
Independent Director
Independent Director
25.91K
--
Katrina L. Houde
Katrina L. Houde
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--

よくある質問

Lifecore Biomedical Incの上位5名の株主は誰ですか?

Lifecore Biomedical Incの上位5名の株主は以下のとおりです。Mr. Paul Josephs

Lifecore Biomedical Inc(LFCR)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Lifecore Biomedical Incの株式を保有している機関は225社あり、保有株式の総市場価値は約30.56Mで、全体の81.48%を占めています。2025Q4と比較して、機関の持ち株は1031462.00増加しています。

Lifecore Biomedical Incの最大の収益源は何ですか?

2026Q1において、Contract development and manufacturing organization ("CDMO")部門がLifecore Biomedical Incにとって最大の収益を生み出しており、その金額は17.81Mで、全収益の64.53%を占めています。